NDC Code(s) : 0145-0020-03, 0145-0020-02, 0145-0020-62
Packager : Stiefel Laboratories, Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Fabiortazarotene AEROSOL, FOAM | |||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
PRODUCT DISPLAY PANEL
NDC 0145-0020-03
Fabior®
(tazarotene) Foam, 0.1%
50 grams
For topical use only
Store upright
Rx only
©2014 Stiefel Laboratories, Inc.
Rev. 5/14
10000000124106
![Fabior 50 g carton](/xml/596fd7d0-6ae2-4736-990d-4d4f01f96965/fabior-spl-graphic-08.jpg)